Literature DB >> 2409272

Comparative interactions of organic Ca++ channel antagonists with myocardial Ca++ and K+ channels.

J R Hume.   

Abstract

Dose-dependent inhibition by three organic calcium channel antagonists, D-600, nisoldipine and diltiazem, of the inward calcium current (iCa) and the delayed, outward potassium current (iK) in single frog atrial cells was examined using a voltage clamp technique. At holding potentials of -60 mV, low concentrations of these antagonists produced considerable inhibition of iCa without significant alterations in iK, suggesting that iK in single frog atrial cells is not a calcium-activated K+ conductance. Higher concentrations of each of these antagonists, however, inhibited iK. The estimated Kd values for inhibition of iCa and iK, respectively, were 3.7 X 10(-7) M and 8.2 X 10(-4) M for D-600, 1.6 X 10(-8) M and 1.6 X 10(-5) M for nisoldipine and 4.4 X 10(-6) M and 3.3 X 10(-4) M for diltiazem. Under these experimental conditions, D-600 and nisoldipine interact more selectively with myocardial Ca++ channels than K+ channels compared to diltiazem, which is less selective. In addition, the inhibition of iK by each of these antagonists was found to exhibit an apparent voltage dependence; block was enhanced at more negative membrane potentials and relieved at more positive membrane potentials. This voltage-dependent block of iK is, therefore, opposite to the voltage-dependent inhibition of iCa produced by these compounds, where block of iCa is accentuated at positive membrane potentials.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409272

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Properties of the potassium conductances of principal cells of rat cortical collecting ducts.

Authors:  E Schlatter; E Lohrmann; R Greger
Journal:  Pflugers Arch       Date:  1992-01       Impact factor: 3.657

2.  Cytosolic calcium regulates a potassium current in corn (Zea mays) protoplasts.

Authors:  K A Ketchum; R J Poole
Journal:  J Membr Biol       Date:  1991-02       Impact factor: 1.843

3.  The calcium antagonist D600 inhibits calcium-independent transient outward current in isolated rat ventricular myocytes.

Authors:  I A Lefevre; A Coulombe; E Coraboeuf
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

4.  Effect of UK-84149 on voltage-activated calcium currents of single smooth muscle cells from guinea-pig and rabbit jejunum and rabbit coronary artery.

Authors:  H Zhang; T B Bolton
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Bay K 8644 induce enhancement of K+ current in both single heart cell and smooth muscle cell.

Authors:  J F Renaud; G Bkaily; M Benabderrazik; D Jacques; N Sperelakis
Journal:  Mol Cell Biochem       Date:  1988 Mar-Apr       Impact factor: 3.396

6.  Characterization of dihydropyridine-sensitive calcium channels in rat brain synaptosomes.

Authors:  J J Woodward; M E Cook; S W Leslie
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

7.  Calcium current in isolated neonatal rat ventricular myocytes.

Authors:  N M Cohen; W J Lederer
Journal:  J Physiol       Date:  1987-10       Impact factor: 5.182

8.  A whole-cell patch clamp technique which minimizes cell dialysis.

Authors:  J R Hume; R N Leblanc
Journal:  Mol Cell Biochem       Date:  1988 Mar-Apr       Impact factor: 3.396

Review 9.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

10.  Inhibitory effects of dihydropyridines on macroscopic K+ currents and on the large-conductance Ca(2+)-activated K+ channel in cultured cerebellar granule cells.

Authors:  L Fagni; J L Bossu; J Bockaert
Journal:  Pflugers Arch       Date:  1994-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.